Treating restless legs syndrome: current pathophysiological concepts and clinical trials

JOURNAL ARTICLE published April 2002 in Expert Opinion on Investigational Drugs

Authors: Bjorn Wito Walther

Emerging concepts in cardiovascular disease: should elevated serum uric acid be considered a risk factor?

JOURNAL ARTICLE published January 1998 in Expert Opinion on Investigational Drugs

Authors: David J Dzielak | Salah D Kivlighn

JOURNAL ISSUE published July 1994 in Expert Opinion on Investigational Drugs

Head injury therapies

JOURNAL ARTICLE published October 1997 in Expert Opinion on Investigational Drugs

Authors: Laurence T Dunn

Metabolic Diseases Drug Discovery World Summit

JOURNAL ARTICLE published October 2003 in Expert Opinion on Investigational Drugs

Authors: Ramkanth Sarabu

Pharma now needs more than mergers

JOURNAL ARTICLE published February 2004 in Expert Opinion on Investigational Drugs

Authors: Phillip Wiggins

Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin

JOURNAL ARTICLE published January 2011 in Expert Opinion on Investigational Drugs

Authors: Adam J Foley-Comer | Anne-Marie Young | Fiona Russell-Yarde | Paul Jordan

Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease

JOURNAL ARTICLE published 3 May 2020 in Expert Opinion on Investigational Drugs

Authors: Sameem M. Abedin | Mehdi Hamadani

An overview of developing TNF-α targeted therapy for the treatment of psoriasis

JOURNAL ARTICLE published 3 October 2015 in Expert Opinion on Investigational Drugs

Authors: Molly Campa | Caitriona Ryan | Alan Menter

JOURNAL ISSUE published November 1998 in Expert Opinion on Investigational Drugs

Related articles

JOURNAL ARTICLE published May 2012 in Expert Opinion on Investigational Drugs

Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)

JOURNAL ARTICLE published January 2003 in Expert Opinion on Investigational Drugs

Authors: Lucila MA Agle | Margalit Rosenkranz | Thomas JA Lehman

JOURNAL ISSUE published November 2000 in Expert Opinion on Investigational Drugs

What are we looking for in new antibacterials and how do we design it?

JOURNAL ARTICLE published February 2006 in Expert Opinion on Investigational Drugs

Authors: John F Barrett | Mary Motyl

JOURNAL ISSUE published December 1995 in Expert Opinion on Investigational Drugs

Clinical pharmacology study of the corticosteroid nasal spray dexamethasone cipecilate (NS-126): examination of the durability of efficacy in the nasal induction test

JOURNAL ARTICLE published December 2010 in Expert Opinion on Investigational Drugs

Authors: Minoru Gotoh | Kimihiro Okubo | Minoru Okuda | Chikuma Hamada

Investigational therapies for the treatment of narcolepsy

JOURNAL ARTICLE published 3 August 2017 in Expert Opinion on Investigational Drugs

Authors: Stefano de Biase | Annacarmen Nilo | Gian Luigi Gigli | Mariarosaria Valente

Rituximab for refractory Wegener’s granulomatosis

JOURNAL ARTICLE published September 2006 in Expert Opinion on Investigational Drugs

Authors: Sabina A Antoniu

Targeting the subtypes of breast cancer: rethinking investigational drugs

JOURNAL ARTICLE published February 2012 in Expert Opinion on Investigational Drugs

Authors: Giuseppe Curigliano | Marzia Locatelli | Luca Fumagalli | Janaina Brollo | Elisabetta Munzone | Franco Nolé | Carmen Criscitiello | Aron Goldhirsch

Targeting leukemia inhibitory factor in pancreatic adenocarcinoma

JOURNAL ARTICLE published 4 May 2023 in Expert Opinion on Investigational Drugs

Authors: Jing Wang | Christian Karime | Umair Majeed | Jason S. Starr | Mitesh J. Borad | Hani M. Babiker